Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs9539792 | chr13:64106622 | C/T | 2.74E-5 | 178 | 22.63 | 22.63 | 26.57 | KM Plot |
PCPG | rs9547705 | chr13:37520248 | C/A | 0.000345 | 174 | 4.17 | 19.1 | 26.57 | KM Plot |
PCPG | rs9547707 | chr13:37541423 | G/T | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs9547725 | chr13:37641637 | A/G | 0.000356 | 174 | 4.17 | 24.23 | 26.27 | KM Plot |
PCPG | rs954889 | chr8:126143786 | C/T | 3.01E-5 | 178 | 4.17 | 28.87 | 25.4 | KM Plot |
PCPG | rs9576148 | chr13:37552386 | A/G | 0.000329 | 176 | 4.17 | 24.23 | 25.7 | KM Plot |
PCPG | rs9576153 | chr13:37580768 | C/A | 0.000272 | 178 | 4.17 | 25 | 25.47 | KM Plot |
PCPG | rs9576154 | chr13:37581051 | T/G | 0.000285 | 178 | 4.17 | 24.7 | 25.7 | KM Plot |
PCPG | rs9577558 | chr13:114145199 | C/T | 3.64E-12 | 177 | 24.23 | 29.5 | 3.32 | KM Plot |
PCPG | rs9577559 | chr13:114155368 | G/A | 4.65E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs9577567 | chr13:114183365 | A/G | 5.45E-12 | 176 | 24.1 | 30.33 | 3.32 | KM Plot |
PCPG | rs9594181 | chr13:37537967 | T/C | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs9603121 | chr13:37543158 | A/G | 0.000337 | 176 | 4.17 | 24.17 | 25.87 | KM Plot |
PCPG | rs9613274 | chr22:21273168 | A/G | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs9614653 | chr22:45767391 | A/G | 2.45E-9 | 178 | 14.5 | 25.18 | 25.6 | KM Plot |